Medicinal cannabis company Tilray saw a robust response to its IPO on the Nasdaq Thursday. TheStreet talks with Tilray's CEO Brendan Kennedy about the company's prospects.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday's trending stocks from the floor of the New York Stock Exchange
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer interviewed marijuana company Canopy Growth's CEO Bruce Linton.
When a cannabis company needs money to fuel growth, it's never as simple as heading to the bank to shop investors.
Rock legend Gene Simmons is all in on cannabis despite being notoriously anti drugs and alcohol.
From dog treats to face wash, these are the next big thing in cannabis.
MedMen is now selling shares on the Canadian Securities Exchange. Here's why it still isn't possible for the $1.65 billion company to list in its home country.
LeafLink is an online marketplace that connects buyers and sellers of legal marijuana.
Traditional, blue-chip stocks and FANG just aren't cutting it right now. Smart investors will consider alternative strategies to diversify out of the same-old, same-old.
What was once a red and blue issue has now attracted a growing set of proponents from both sides of the aisle.